Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study - Institut Pasteur Access content directly
Journal Articles Clinical Microbiology and Infection Year : 2017

Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study

E. Muth
  • Function : Author
M. Gratigny
  • Function : Author
A. Lamamy
  • Function : Author
J. Cheval
  • Function : Author
L. de Visser
  • Function : Author
F. Jagorel
  • Function : Author
L. Ben Yahia
  • Function : Author
G. Bamba
  • Function : Author
M. Dubois
  • Function : Author
A. Lefort
  • Function : Author

Abstract

Objective: Infections are the major cause of morbidity and mortality in immunocompromised patients. Improving microbiological diagnosis in these patients is of paramount clinical importance. Methods: We performed this multicentre, blinded, prospective, proof-of-concept study, to compare untargeted next-generation sequencing with conventional microbiological methods for first-line diagnosis of infection in 101 immunocompromised adults. Patients were followed for 30 days and their blood samples, and in some cases nasopharyngeal swabs and/or biological fluids, were analysed. At the end of the study, expert clinicians evaluated the results of both methods. The primary outcome measure was the detection rate of clinically relevant viruses and bacteria at inclusion. Results: Clinically relevant viruses and bacteria identified by untargeted next-generation sequencing and conventional methods were concordant for 72 of 101 patients in samples taken at inclusion (k test ¼ 0.2, 95% CI 0.03-0.48). However, clinically relevant viruses and bacteria were detected in a significantly higher proportion of patients with untargeted next-generation sequencing than conventional methods at inclusion (36/101 (36%) vs. 11/101 (11%), respectively, p <0.001), and even when the latter were continued over 30 days (19/101 (19%), p 0.003). Untargeted next-generation sequencing had a high negative predictive value compared with conventional methods (64/65, 95% CI 0.95e1). Conclusions: Untargeted next-generation sequencing has a high negative predictive value and detects more clinically relevant viruses and bacteria than conventional microbiological methods. Untargeted next-generation sequencing is therefore a promising method for microbiological diagnosis in immu-nocompromised adults.

Dates and versions

pasteur-02185125 , version 1 (16-07-2019)

Identifiers

Cite

P. Parize, E. Muth, C. Richaud, M. Gratigny, B. Pilmis, et al.. Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study. Clinical Microbiology and Infection, 2017, 23 (8), pp.574.e1-574.e6. ⟨10.1016/j.cmi.2017.02.006⟩. ⟨pasteur-02185125⟩
48 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More